(Total Views: 344)
Posted On: 09/28/2021 6:50:38 PM
Post# of 36541
Krilac,I’d be interested in your take on the “Complete Vaccine “ … given the timeframes for trials and approval and the trajectory for the pandemic … Is it even relevant in any SP estimate? The NGIO valuation is pre COVID. I think any potential for the “Complete Vaccine “ depends on if the booster efficacy wanes over time …
(0)
(0)Scroll down for more posts ▼
